FDA recall, , Low risk
Huvepharma Amprol 25% Type A Medicated Article
Amprol 25% (amprolium) Type A medicated article is missing its lot number and expiration date on one bag.
Summary by Recall Canary from the FDA notice
What happened
HUVEPHARMA EOOD is recalling Amprol 25% (amprolium), Type A medicated article, Net Wt.: 50lb (22.68 kg), manufactured by HUVEPHARMA, INC., St Louis, MO 63116 and distributed by HUVEPHARMA, INC., Peachtree City, GA 30269, because one bag is missing its lot number and expiration date. The recall began April 2, 2026, and the product was distributed nationwide within the U.S.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
AMPROL 25% (amprolium), Type A medicated article
- NDC
- 23243-9561-5
- Lot code
- XSC442
Recall details
- Company began the recall
- Sold in
Within U.S Nationwide.
- Company
- HUVEPHARMA EOOD
- Hazard
- Labeling error
- Risk
Low risk
It is unlikely to cause health problems in animals it is used on.
FDA Class III recall · How risk is rated
- Event ID
- 98712
- Recall number
- V-0120-2026
- Quantity recalled
- 241 bags @ 50.0 lbs each, 12,050.0 lbs
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Listed on Recall Canary
Summary updated